Autoimmune Therapy Biz Raises $80M In Series B Round
Biotechnology company Pandion Therapeutics said Wednesday it had raised $80 million in a funding round that drew support from all of its existing venture capital backers as well as several new...To view the full article, register now.
Already a subscriber? Click here to view full article